Biocon Limited (NSE:BIOCON)

Biocon Revenue

Biocon had revenue of 43.36B INR in the quarter ending June 30, 2026, with 10.00% growth. This brings the company's total for the last twelve months to 173.21B, up 9.83% year-over-year. In the fiscal year ending March 31, 2026, Biocon had annual revenue of 169.27B with 10.91% growth. That makes Biocon the 5,280th largest company in the world by revenue and 171st in India.

• Revenue (ttm): 173.21B
• Revenue Growth: +9.83%
• P/S Ratio: 3.11
• Revenue / Employee: 10.53M
• Employees: 16,447
• Market Cap: 526.75B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Biosimilars 104.31B 60.2%
• Services 37.39B 21.6%
• Generics 31.68B 18.3%

By Geography

Chart

• United States of America 79.95B 47.2%
• European Union (Including Ireland) 46.17B 27.3%
• Rest of The World 33.98B 20.1%
• India 9.18B 5.4%

Fiscal year ended Mar 31, 2026 See the full Biocon breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	169.27B	16.65B	10.91%
Mar 31, 2025	152.62B	5.06B	3.43%
Mar 31, 2024	147.56B	35.82B	32.05%
Mar 31, 2023	111.74B	29.90B	36.54%
Mar 31, 2022	81.84B	10.41B	14.57%

Data Source: S&P Global Market Intelligence Last updated: Aug 5, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 21, 2026

Data Sources Report a data error